EUVIMEDEUVIMED entdecken
Open Access

Evaluation of willingness to obtain of Covid 19 vaccine in patients with multiple sclerosis

Masoud Ghiasian, Maryam Farhadian, Alireza Salehzadeh

American Journal of Neurodegenerative Disease · 2024

DOI: 10.62347/occz6431 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Neurodegenerative Disease, 2024. Verfasst von Masoud Ghiasian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroimmunology, School of Medicine, Hamadan University of Medical Sciences Hamadan, Iran. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Vaccinationcoronavirus disease 2019multiple sclerosisvaccine acceptance

Autor:innen und Institutionen

  • Department of Neuroimmunology, School of Medicine, Hamadan University of Medical Sciences Hamadan, Iran.
  • Department of Biostatistics, School of Public Health, Hamadan University of Medical Sciences Hamadan, Iran.
  • School of Medicine, Hamadan University of Medical Sciences Hamadan, Iran.

Zitieren

APA

Ghiasian, M., Farhadian, M., & Salehzadeh, A. (2024). Evaluation of willingness to obtain of Covid 19 vaccine in patients with multiple sclerosis. American Journal of Neurodegenerative Disease. https://doi.org/10.62347/occz6431

Vancouver

Ghiasian M, Farhadian M, Salehzadeh A. Evaluation of willingness to obtain of Covid 19 vaccine in patients with multiple sclerosis. American Journal of Neurodegenerative Disease. 2024. doi:10.62347/occz6431

BibTeX
@article{Ghiasian2024,
  author = {Ghiasian, Masoud and Farhadian, Maryam and Salehzadeh, Alireza},
  title = {Evaluation of willingness to obtain of Covid 19 vaccine in patients with multiple sclerosis},
  journal = {American Journal of Neurodegenerative Disease},
  year = {2024},
  doi = {10.62347/occz6431}
}
Kostenlos starten →